MOUNTAIN VIEW, Calif., Feb. 4, 2019 /PRNewswire/ -- Omnicell, Inc., (NASDAQ: OMCL), has earned top honors in the 2019 Best in KLAS: Software & Services report, receiving the prestigious Best in KLAS Automated Dispensing Cabinets designation for the 13th consecutive year. Omnicell has been consistently recognized as the top vendor in this category by KLAS, an independent healthcare research firm, which uses ratings from thousands of healthcare professionals to determine the top-performing vendors.
Omnicell also received Category Leader distinction across all pharmacy automation segments, including IV Robots, Medication Carousels, and Pharmacy Robots (Oral Solid).
"We are proud to once again receive these top honors from KLAS, as leading-edge automation is the cornerstone of our Autonomous Pharmacy vision," said Randall A. Lipps, founder, chairman, president, and CEO of Omnicell. "This recognition serves as a testament to our commitment to delivering innovative solutions that improve patient safety, simplify workflow, reduce risk, and ultimately decrease costs."
Autonomous Pharmacy is Omnicell's vision to develop a zero error, fully automated medication management infrastructure. Considering every medication dose as a digital node on the network across the continuum of care, Autonomous Pharmacy leverages autonomous workflows, powered by Omnicell's cloud data platform, to provide rich data insights and optimization recommendations that support clinical, operational, compliance, and population healthcare challenges. Through the Autonomous Pharmacy vision, pharmacists, nurses, clinicians, and pharmacy staff will be more empowered to focus on patient and clinician satisfaction, helping to improve patient care, reduce errors, enhance safety, and provide new opportunities for growth.
Omnicell is integrating its current offerings and technologies while investing in the most comprehensive set of solutions across three key areas: innovative automation solutions to streamline workflows, predictive intelligence to better understand medication usage, and expert services that support improved efficiency, compliance, and patient outcomes.
"Best in KLAS is about raising the bar for healthcare technology. Its providers and payers demanding better performance, usability, and interoperability," said Adam Gale, president of KLAS. "Ultimately, Best in KLAS is about giving providers and payers the tools they need to facilitate superior care and improved outcomes."
About KLAS
KLAS is a data-driven company on a mission to improve the world's healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.
About Omnicell
Since 1992, Omnicell has been inspired to create safer and more efficient ways to manage medications across all care settings. Through our industry-leading medication management platform that spans the continuum of care, Omnicell is developing a vision for a fully automated infrastructure, powered by a cloud data platform that supports improved patient care, fewer errors, enhanced safety, and new opportunities for growth.
Omnicell's vision for Autonomous Pharmacy integrates a comprehensive set of solutions across three key areas: Automation solutions designed to digitize and streamline workflows; Intelligence that provides actionable insights to better understand medication usage and improve pharmacy supply chain management; and Work – expert services that serve as an extension of pharmacy operations to support improved efficiency, regulatory compliance, and patient outcomes.
Over 5,000 facilities worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. And more than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
Omnicell's innovative medication adherence solutions, used by over 40,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
To learn more about Omnicell and our Autonomous Pharmacy vision, please visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
SOURCE Omnicell, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article